The Lymphoma Research Foundation's (LRF) Sixth Annual Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop was attended by some 60 mantle cell lymphoma (MCL) specialists from around the world.
Attendees heard presentations addressing several key issues including the biology of MCL, prognostic indicators, new molecular targets, chemoimmunotherapy, transplantation and novel therapeutic approaches.
AdvertisementThe MCLC was established by the Lymphoma Research Foundation (LRF) in 2005 to accelerate the pace of mantle cell lymphoma research. Attendees to this year's workshop included: LRF MCLC members, including LRF MCL grant recipients as well as other scientific investigators conducting cutting-edge research.
As in the past, this year's meeting provided a unique opportunity for experts to report on their research findings and exchange ideas on how to best improve treatment options for individuals living with MCL. Those in attendance heard 17 oral presentations, viewed 9 poster presentations and participated in 6 roundtable discussions covering areas such as: Clinical Trails for Younger Patients, Epigenetic Studies in MCL and Cell Cycle Targets for MCL.